NEUTRA CORPORATION (NTRR) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 74 203 sessions, October 15, 2025 to October 15, 2026
- Largest daily move
- +100% close of November 25, 2025
- 1-year change
- +0% closing prices, October 15, 2025 to October 15, 2026
- 1-month change
- +0% closing prices, September 11, 2026 to October 15, 2026
Company Description
NEUTRA CORPORATION (OTC: NTRR) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $291.8K.
NTRR has gained 0.0% over the past year. The last closing price was $0.0002.
For FY2023, NEUTRA CORPORATION reported revenue of $68K.
This page collects what Stock Titan holds for NTRR, including price data, latest news, and financial highlights.
Stock Performance
NEUTRA CORPORATION (NTRR) closed at $0.0002 on October 15, 2026. Over the past 12 months, the price has gained 0.0%.
NTRR Metrics & Rankings
Price returns through October 15, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
NEUTRA CORPORATION has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, clinical trial. View all NTRR news →
SEC Filings
Financial Highlights
NEUTRA CORPORATION generated $68K in revenue in FY2023, retaining a 51.9% gross margin, and operating income reached -$298K (-437.8% operating margin). The company generated -$153K in operating cash flow. The current ratio was 0.03, measuring current assets divided by current liabilities.
Upcoming Events
NTRR Company Profile & Sector Positioning
NEUTRA CORPORATION (NTRR) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing NTRR often look at related companies in the same sector, including PHARMAGREEN BIOTECH INC (PHBI), AEQUUS PHARMACEUTICAL INC (AQSZF), GOLD RIVER PRODS INC (GRPS), GELSTAT CORP (GSAC), and VIBE GROWTH CORP (VIBEF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NTRR's relative position within its industry.